Found: 9
Select item for more details and to access through your institution.
Synthetic modified N-POMC<sub>1–28</sub> controls in vivo proliferation and blocks apoptosis in rat adrenal cortex.
- Published in:
- Cell & Tissue Research, 2010, v. 341, n. 2, p. 239, doi. 10.1007/s00441-010-0998-0
- By:
- Publication type:
- Article
POD-1/TCF21 Reduces SHP Expression, Affecting LRH-1 Regulation and Cell Cycle Balance in Adrenocortical and Hepatocarcinoma Tumor Cells.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Expression of Insulin-Like Growth Factor-II and Its Receptor in Pediatric and Adult Adrenocortical Tumors.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2008, v. 93, n. 9, p. 3524, doi. 10.1210/jc.2008-0065
- By:
- Publication type:
- Article
The tyrosine kinase inhibitor nilotinib is more efficient than mitotane in decreasing cell viability in spheroids prepared from adrenocortical carcinoma cells.
- Published in:
- Cancer Cell International, 2018, v. 18, p. 1, doi. 10.1186/s12935-018-0527-x
- By:
- Publication type:
- Article
TCF21/POD-1, a Transcritional Regulator of SF-1/NR5A1, as a Potential Prognosis Marker in Adult and Pediatric Adrenocortical Tumors.
- Published in:
- Frontiers in Endocrinology, 2018, p. 1, doi. 10.3389/fendo.2018.00038
- By:
- Publication type:
- Article
The Involvement of Nek2 and Notch in the Proliferation of Rat Adrenal Cortex Triggered by POMC-Derived Peptides.
- Published in:
- PLoS ONE, 2014, v. 9, n. 10, p. 1, doi. 10.1371/journal.pone.0108657
- By:
- Publication type:
- Article
Stathmin 1 is highly expressed and associated with survival outcome in malignant adrenocortical tumours.
- Published in:
- Investigational New Drugs, 2020, v. 38, n. 3, p. 899, doi. 10.1007/s10637-019-00846-9
- By:
- Publication type:
- Article
Comparative effect of ACTH and Related Peptides on Proliferation and Growth of Rat Adrenal Gland.
- Published in:
- Frontiers in Endocrinology, 2016, p. 1, doi. 10.3389/fendo.2016.00039
- By:
- Publication type:
- Article
N-type calcium channel v2.2 is a target of TCF21 in adrenocortical carcinomas.
- Published in:
- Neoplasma, 2022, v. 69, n. 4, p. 899, doi. 10.4149/neo_2022_220106N25
- By:
- Publication type:
- Article